UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

An analysis of FDA-approved drugs for infectious disease: antibacterial agents

Drug discovery today, 2014-09, Vol.19 (9), p.1283-1287

2014

Volltextzugriff (PDF)

An overview of FDA-approved biologics medicines

Drug discovery today, 2015-04, Vol.20 (4), p.393-398

Kinch, Michael S.

2015

Volltextzugriff (PDF)

An overview of FDA-approved vaccines & their innovators

Expert review of vaccines, 2017-12, Vol.16 (12), p.1253-1266

2017

Volltextzugriff (PDF)

Innovator Organizations in New Drug Development: Assessing the Sustainability of the Biopharmaceutical Industry

Cell chemical biology, 2016-06, Vol.23 (6), p.644-653

2016

Volltextzugriff (PDF)

An analysis of FDA-approved drugs: natural products and their derivatives

Drug discovery today, 2016-02, Vol.21 (2), p.204-207

2016

Volltextzugriff (PDF)

WANTED DEAD OR ALIVE: New Thinking to Incentivize Drug Development

Pharmaceutical research, 2024-02, Vol.41 (2), p.199-202

Kinch, Michael S.

2024

Volltextzugriff (PDF)

An overview of FDA-approved new molecular entities: 1827–2013

Drug discovery today, 2014-08, Vol.19 (8), p.1033-1039

2014

Volltextzugriff (PDF)

Fiduciary responsibility

Drug discovery today, 2023-11, Vol.28 (11), p.103794-103794, Article 103794

Kinch, Michael S.

2023

Volltextzugriff (PDF)

The pharmaceutical innovator’s dilemma

Drug discovery today, 2023-09, Vol.28 (9), p.103699-103699, Article 103699

Kinch, Michael S.

2023

Volltextzugriff (PDF)

Keeping apace on the pharmaceutical treadmill

Drug discovery today, 2023-07, Vol.28 (7), p.103630-103630, Article 103630

Kinch, Michael S

2023

Volltextzugriff (PDF)

An analysis of FDA-approved drugs for oncology

Drug discovery today, 2014-12, Vol.19 (12), p.1831-1835

Kinch, Michael S.

2014

Volltextzugriff (PDF)

Monoclonal antibodies: Trends in therapeutic success and commercial focus

Drug discovery today, 2023-01, Vol.28 (1), p.103415-103415, Article 103415

2023

Volltextzugriff (PDF)

An analysis of FDA-approved drugs for cardiovascular diseases

Drug discovery today, 2016-01, Vol.21 (1), p.1-4

2016

Volltextzugriff (PDF)

Antibiotic Development: Lessons from the Past and Future Opportunities

Pharmaceutical research, 2024-05, Vol.41 (5), p.839-848

2024

Volltextzugriff (PDF)

2023 in review: FDA approvals of new medicines

Drug discovery today, 2024-05, Vol.29 (5), p.103966-103966, Article 103966

2024

Volltextzugriff (PDF)

2022 in review: FDA approvals of new medicines

Drug discovery today, 2023-08, Vol.28 (8), p.103622-103622, Article 103622

2023

Volltextzugriff (PDF)

2021 in review: FDA approvals of new medicines

Drug discovery today, 2022-08, Vol.27 (8), p.2057-2064

2022

Volltextzugriff (PDF)

EphA2 overexpression causes tumorigenesis of mammary epithelial cells

Cancer research (Chicago, Ill.), 2001-03, Vol.61 (5), p.2301-2306

2001

Volltextzugriff (PDF)

Predictive Value of the EphA2 Receptor Tyrosine Kinase in Lung Cancer Recurrence and Survival

Clinical cancer research, 2003-02, Vol.9 (2), p.613-618

2003

Volltextzugriff (PDF)

EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma

Clinical cancer research, 2004-08, Vol.10 (15), p.5145-5150

2004

Volltextzugriff (PDF)

Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focus

Drug discovery today, 2023-03, Vol.28 (3), p.103462-103462, Article 103462

2023

Volltextzugriff (PDF)

VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: Implications for vasculogenic mimicry

Cancer biology & therapy, 2006-02, Vol.5 (2), p.228-233

2006

Volltextzugriff (PDF)

The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza

Virology (New York, N.Y.), 2009-05, Vol.387 (2), p.473-481

2009

Volltextzugriff (PDF)

2020 in review: FDA approvals of new medicines

Drug discovery today, 2021-12, Vol.26 (12), p.2794-2799

2021

Volltextzugriff (PDF)

Sources of innovation for new medicines: questions of sustainability

Drug discovery today, 2021-01, Vol.26 (1), p.240-247

2021

Volltextzugriff (PDF)

1 – 25 von 2.423

Menü

Weitere Dienste

Einstellungen

An analysis of FDA-approved drugs for infectious disease: antibacterial agents

An overview of FDA-approved biologics medicines

An overview of FDA-approved vaccines & their innovators

Innovator Organizations in New Drug Development: Assessing the Sustainability of the Biopharmaceutical Industry

An analysis of FDA-approved drugs: natural products and their derivatives

WANTED DEAD OR ALIVE: New Thinking to Incentivize Drug Development

An overview of FDA-approved new molecular entities: 1827–2013

Fiduciary responsibility

The pharmaceutical innovator’s dilemma

Keeping apace on the pharmaceutical treadmill

An analysis of FDA-approved drugs for oncology

Monoclonal antibodies: Trends in therapeutic success and commercial focus

An analysis of FDA-approved drugs for cardiovascular diseases

Antibiotic Development: Lessons from the Past and Future Opportunities

2023 in review: FDA approvals of new medicines

2022 in review: FDA approvals of new medicines

2021 in review: FDA approvals of new medicines

EphA2 overexpression causes tumorigenesis of mammary epithelial cells

Predictive Value of the EphA2 Receptor Tyrosine Kinase in Lung Cancer Recurrence and Survival

EphA2 Expression Is Associated with Aggressive Features in Ovarian Carcinoma

Immunoconjugates and bispecific antibodies: Trends in therapeutic success and commercial focus

VE-cadherin regulates EphA2 in aggressive melanoma cells through a novel signaling pathway: Implications for vasculogenic mimicry

The use of Random Homozygous Gene Perturbation to identify novel host-oriented targets for influenza

2020 in review: FDA approvals of new medicines

Sources of innovation for new medicines: questions of sustainability

Suchergebnisse filtern